A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.
Based on current operating plans, and assuming full execution of the $125 million share repurchase plan, we expect our ...
More than two dozen contributors to the manual criticized the deletion of a chapter on climate science by the Federal Judicial Center. By Karen Zraick Leticia Carvalho heads a global authority that’s ...
Background Cardiovascular disease (CVD) is the leading cause of mortality worldwide, while depression is highly prevalent in this patient population and has long been regarded as an independent risk ...
Don’t start with moon shots. by Thomas H. Davenport and Rajeev Ronanki In 2013, the MD Anderson Cancer Center launched a “moon shot” project: diagnose and recommend treatment plans for certain forms ...